Real-World Study of Ceftazidime Avibactam in China

TerminatedOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

October 20, 2022

Primary Completion Date

July 11, 2024

Study Completion Date

July 11, 2024

Conditions
Hospital Acquired PneumoniaVentilator Acquired PneumoniaComplicated Intra Abdominal Infections
Interventions
DRUG

ceftazidime avibactam group

Non-Interventional Study

Trial Locations (17)

200040

Huashan Hospital Fudan University, Shanghai

Unknown

Beijing Tsinghua Changgung Hospital, Beijing

Xiangya Hospital Central South University, Changsha

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

The First affiliated Hospital of Anhui Medical University, Hefei

The First Affiliated Hospital of Nanchang University, Nanchang

Zhongda Hospital Southeast University, Nanjing

The Affiliated People's Hospital of Ningbo University, Ningbo

Shanghai Tenth People's Hospital, Shanghai

The Second People's Hospital of Hebei Medical University, Shijiazhuang

The Third Hospital of Hebei Medical University, Shijiazhuang

The First Affiliated Hospital of Soochow University, Suzhou

Tianjin Medical University General Hospital, Tianjing

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

Henan Provincial People's Hospital, Zhengzhou

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY